1508 (1508) Fair Value & Analysis

Financial Services · Market cap HK$46.7B

1 1508 1508 · HK

PriceHK$1.11

Fair ValueHK$2.22

Upside+100.0%

Quality55/100

Watch 1508 for free — get notified when fair value or trend changes. Watch for free

Evidence: High Range HK$1.66 – HK$2.78

Fair value as of: Jul 2, 2026

From 24 valuation models · updated today

Share price −4.0% over the past month.

Price vs Fair Value (12 months)

12‑month range HK$1.04 – HK$1.73 · fair‑value band HK$1.66 – HK$2.78 · the HK$1.11 price screens below the HK$2.22 fair value. As of Jul 2, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

1508 (1508) currently trades at HK$1.11, while our model-based Fair Value estimate is HK$2.22 — implying the stock looks roughly 100.0% undervalued today. We read business quality at 55/100 (solid quality), in the Financial Services sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.

Over the trailing twelve months, 1508 generated revenue of HK$108B at a net margin of 9.1%. Revenue grew 9.3% year over year. It earns a return on equity of 8.8%. The balance sheet holds a net cash position of HK$2.8B. Fundamentals as of Jul 2, 2026

Key figures & financial health

Revenue (TTM) HK$108B

Revenue growth (YoY) +9.3%

Net margin 9.1%

Return on equity 8.8%

Free cash flow HK$28.2B FY2025

P/E ratio 4.1

More key figures

Operating margin 10.8%

EPS (TTM) HK$0.1500

Dividend yield 6.2%

EPS growth (YoY) -29.6%

Net cash HK$2.8B FY2025

Figures from reported company fundamentals (EODHD) · as of Jul 2, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

1508 reported revenue of HK$113B in FY2025 versus HK$164B in FY2021, a compound −8.9%/yr. Reported net income was HK$9.5B in FY2025, compounding +12.4%/yr from FY2021.

Revenue −8.9%/yr

FY21 HK$164B

FY22 HK$88.3B

FY23 HK$95.0B

FY24 HK$85.5B

FY25 HK$113B

Net income +12.4%/yr

FY21 HK$6.0B

FY22 −HK$325M

FY23 HK$5.7B

FY24 HK$10.6B

FY25 HK$9.5B

Is 1508 fairly valued? → Check now

Similar stocks

6 more Insurance - Reinsurance stocks, each showing price versus our Fair Value estimate (as of Jul 2, 2026).

Stock	Price	Fair Value	vs Fair Value
MURGF MURGF	$536.40	$789.39	+47%
MURGY MURGY	$10.59	$15.17	+43%
MUV2 MUV2	€460.30	€687.22	+49%
Swiss Re AG SSREY	$38.99	$52.50	+35%
Hannover Rück SE HVRRF	$267.08	$534.15	+100%
Everest Group E1VE34	R$520.21	R$787.97	+51%

Explore undervalued stocks

More undervalued Financial Services stocks →

All undervalued stocks Technology Financial Services Healthcare Consumer Cyclical Consumer Defensive Communication Services Industrials Energy Basic Materials Real Estate Utilities Deeply Undervalued Stocks Undervalued Blue-Chip Stocks Undervalued Small-Cap Stocks

Frequently asked questions

Is 1508 (1508) undervalued?

As of Jul 2, 2026, our model estimates a fair value of HK$2.22 versus a price of HK$1.11 — about +100% (undervalued). Model-based estimate, not financial advice.

What is the fair value of 1508?

Our model-based fair value for 1508 is HK$2.22 (as of Jul 2, 2026), built from audited fundamentals. The current price is HK$1.11.

What is the quality score of 1508?

1508 has a Quality Score of 55/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

What is the revenue of 1508 (1508)?

1508 reported trailing-twelve-month revenue of about HK$108B (latest available figure, as of Jul 2, 2026).

What is the net profit margin of 1508?

The net profit margin of 1508 is about 9.1%, meaning it keeps roughly 9.1% of revenue as net income. Based on the latest reported figures.

Does 1508 pay a dividend?

1508 currently shows a dividend yield of about 6.22% relative to its recent price (as of Jul 2, 2026).

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.